| Předmět: |
|
| Zdroj: |
Cancer Weekly; 3/14/2023, p688-688, 1p |
| Abstrakt: |
Keywords: Memphis; State:Tennessee; United States; North and Central America; Antineoplastics; Cancer; Cycloparaffins; Diterpenes; Drugs and Therapies; Health and Medicine; Hydrocarbons; Melanoma; Microtubule Proteins; Mitotic Inhibitors; Nerve Tissue Proteins; Oncology; Organic Chemicals; Paclitaxel Therapy; Pharmaceuticals; Taxoids; Terpenes; Tubulin EN Memphis State:Tennessee United States North and Central America Antineoplastics Cancer Cycloparaffins Diterpenes Drugs and Therapies Health and Medicine Hydrocarbons Melanoma Microtubule Proteins Mitotic Inhibitors Nerve Tissue Proteins Oncology Organic Chemicals Paclitaxel Therapy Pharmaceuticals Taxoids Terpenes Tubulin 688 688 1 03/23/23 20230314 NES 230314 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Melanoma have been published. X-ray crystal structure studies and a tubulin polymerization assay confirmed that SB226 is a CBSI that could disrupt the microtubule dynamics and interfere with microtubule assembly. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
